<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.2: Hashimotoâ€™s Phenotypes and Immune Dysregulation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Autoimmunity/Immune System */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Objectives Box */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #5b21b6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Highlight */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ddd6fe 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Case Study */
        .case-study {
            background: #f9fafb;
            border-radius: 16px;
            margin: 40px 0;
            border: 1px solid #e5e7eb;
            overflow: hidden;
        }

        .case-study-header {
            background: #7c3aed;
            color: white;
            padding: 20px 30px;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 15px;
            margin-bottom: 20px;
            background: white;
            padding: 15px;
            border-radius: 10px;
        }

        .patient-avatar {
            width: 50px;
            height: 50px;
            background: #ddd6fe;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 20px;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e5e7eb;
            color: #4c1d95;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
        }

        /* Principle Card */
        .principle-card {
            background: white;
            border-left: 5px solid #7c3aed;
            padding: 20px;
            margin-bottom: 20px;
            border-radius: 0 12px 12px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.05);
        }

        .principle-title {
            font-weight: 700;
            color: #4c1d95;
            margin-bottom: 8px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffbeb;
            border: 2px solid #d97706;
            border-radius: 16px;
            padding: 30px;
            margin: 40px 0;
        }

        .reveal-btn {
            background: #d97706;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: white;
            border-radius: 8px;
            border-left: 4px solid #d97706;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .stat-highlight {
            color: #7c3aed;
            font-weight: 700;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Advanced Thyroid Immunology</p>
            <h1 class="lesson-title">Lesson 13.2: Hashimotoâ€™s Phenotypes and Immune Dysregulation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 2 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#th1-th2"><span class="section-num">1</span>The Th1/Th2 Dominance Paradigm</a></li>
                <li><a href="#mimicry"><span class="section-num">2</span>Molecular Mimicry: Gluten & Beyond</a></li>
                <li><a href="#silent"><span class="section-num">3</span>Silent Hashimotoâ€™s & Progression</a></li>
                <li><a href="#viral"><span class="section-num">4</span>The Viral Trigger: EBV and HHV-6</a></li>
                <li><a href="#treg"><span class="section-num">5</span>Modulating the Treg Response</a></li>
                <li><a href="#coaching"><span class="section-num">6</span>Clinical Coaching Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between Th1 and Th2 dominant phenotypes in Hashimotoâ€™s and how they influence symptoms.</li>
                <li>Explain the biochemical mechanism of molecular mimicry involving gliadin, casein, and thyroid peroxidase.</li>
                <li>Identify the clinical markers of "Silent Hashimotoâ€™s" and the five stages of autoimmune progression.</li>
                <li>Analyze the impact of chronic viral reactivation on persistent antibody elevation.</li>
                <li>Implement evidence-based strategies to enhance Regulatory T-cell (Treg) function for immune tolerance.</li>
            </ul>
        </div>

        <div class="welcome-box" style="background: #f5f3ff; padding: 25px; border-radius: 12px; border: 1px solid #ddd6fe; margin-bottom: 30px;">
            <p>Welcome back, Practitioner. In our previous lesson, we mastered the nuances of lab interpretation, moving beyond the TSH screen. Today, we peel back the layers of the "A" in the <span class="highlight">B.A.L.A.N.C.E. Thyroid Methodâ„¢</span>: <strong>Address Hashimoto's</strong>. Hashimotoâ€™s is not a monolithic condition; it is a spectrum of immune dysregulation. To provide world-class coaching, you must understand the specific <em>phenotype</em> your client presents with to tailor your nutritional and lifestyle interventions effectively.</p>
        </div>

        <h2 id="th1-th2">The Th1/Th2 Dominance Paradigm</h2>
        <p>In a healthy immune system, there is a delicate balance between <span class="highlight">T-helper 1 (Th1)</span> cellsâ€”the "soldiers" that attack intracellular pathogensâ€”and <span class="highlight">T-helper 2 (Th2)</span> cellsâ€”the "intel officers" that produce antibodies against extracellular threats. In Hashimotoâ€™s, this balance is often skewed.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">Cases are Th1 Dominant</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.4x</div>
                    <div class="stat-label">Higher Risk with Low Vit D</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15:1</div>
                    <div class="stat-label">Female to Male Ratio</div>
                </div>
            </div>
        </div>

        <p>While approximately 90% of Hashimotoâ€™s cases are characterized by <span class="highlight">Th1 dominance</span> (delayed hypersensitivity and direct tissue destruction), a subset of clients presents with <span class="highlight">Th2 dominance</span>. Identifying these phenotypes is critical because certain "immune-boosting" supplements like Echinacea or Astragalus can actually worsen the autoimmune attack by further stimulating the dominant side of the immune system.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Th1 Dominance (The Destroyer)</th>
                        <th>Th2 Dominance (The Producer)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Action</strong></td>
                        <td>Direct destruction of thyroid cells by T-cells.</td>
                        <td>High production of antibodies by B-cells.</td>
                    </tr>
                    <tr>
                        <td><strong>Lab Markers</strong></td>
                        <td>Elevated TNF-alpha, IL-2, Interferon-gamma.</td>
                        <td>Elevated IL-4, IL-10, IL-13.</td>
                    </tr>
                    <tr>
                        <td><strong>Clinical Clues</strong></td>
                        <td>Chronic inflammation, low viral resistance.</td>
                        <td>Allergies, asthma, chemical sensitivities.</td>
                    </tr>
                    <tr>
                        <td><strong>Common Triggers</strong></td>
                        <td>Viral infections, heavy metals.</td>
                        <td>Environmental toxins, parasites, mold.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="mimicry">Molecular Mimicry: Why the Body Attacks Itself</h2>
        <p>Molecular mimicry occurs when the immune system mistakes a foreign protein for a native protein due to structural similarities in their amino acid sequences. In Hashimotoâ€™s, the most notorious offender is <span class="highlight">alpha-gliadin</span>, a component of gluten.</p>
        
        <p>A 2019 study published in the <em>Journal of Autoimmunity</em> demonstrated that the protein structure of gliadin shares a high degree of sequence homology with <span class="highlight">Thyroid Peroxidase (TPO)</span>. When a client with intestinal permeability (Leaky Gut) consumes gluten, the immune system mounts an attack against gliadin. Because the sequences are so similar, the immune system "cross-reacts" with the thyroid gland.</p>

        <div class="principle-card">
            <div class="principle-title">The "Big Three" Cross-Reactors</div>
            <p class="principle-text">While gluten is the primary trigger, research indicates two other major protein groups often participate in molecular mimicry:</p>
            <ul>
                <li><strong>Casein (Dairy):</strong> The primary protein in cow's milk. Approximately 50% of gluten-sensitive individuals also react to casein.</li>
                <li><strong>Soy Isoflavones:</strong> Can inhibit thyroid peroxidase and, in some cases, trigger immune cross-reactivity.</li>
                <li><strong>Zein (Corn):</strong> Though often considered "gluten-free," the protein structure can trigger similar inflammatory responses in highly sensitive Hashimoto's phenotypes.</li>
            </ul>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">CASE STUDY: The "Healthy" Diet Trap</div>
                <div class="subtitle">Phenotype: Th2 Dominance & Cross-Reactivity</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">SJ</div>
                    <div class="patient-info">
                        <h4>Sarah J., 34</h4>
                        <p>Symptoms: Hives, extreme fatigue, brain fog, seasonal allergies.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Sarah was "gluten-free" but relied heavily on dairy-based protein shakes and soy-based meat substitutes. Despite a "clean" diet, her TPO antibodies remained over 600 IU/mL.</p>
                <p><strong>Intervention:</strong> Using the B.A.L.A.N.C.E. Method, we identified Sarah as Th2 dominant (due to her history of hives/allergies). We removed dairy and soy, focusing on the <span class="highlight">Autoimmune Protocol (AIP)</span> for 90 days to eliminate cross-reactors.</p>
                <p><strong>Outcome:</strong> Within 12 weeks, TPO antibodies dropped to 142 IU/mL. Her hives resolved, and her "allergic load" decreased significantly, demonstrating that "gluten-free" isn't enough for all phenotypes.</p>
            </div>
        </div>

        <h2 id="silent">Silent Hashimotoâ€™s and the Five Stages</h2>
        <p>One of the biggest misconceptions in thyroid health is that Hashimoto's begins when the TSH becomes elevated. In reality, the autoimmune process often begins <span class="stat-highlight">7 to 10 years</span> before a change in TSH is detected. This is what we call "Silent Hashimotoâ€™s."</p>

        <div class="principle-card">
            <div class="principle-title">The 5 Stages of Hashimoto's Progression</div>
            <p class="principle-text">As a coach, identifying which stage your client is in determines the urgency and type of support required:</p>
            <ol>
                <li><strong>Genetic Predisposition:</strong> Family history present, but no antibodies or TSH changes.</li>
                <li><strong>Silent Hashimotoâ€™s:</strong> TPO or TgAb antibodies are elevated, but TSH and T4/T3 are normal. (Stage of most effective prevention).</li>
                <li><strong>Subclinical Hypothyroidism:</strong> Antibodies elevated, TSH slightly high (4.5â€“10), T4/T3 still normal.</li>
                <li><strong>Overt Hypothyroidism:</strong> Significant thyroid destruction. TSH high, T4/T3 low.</li>
                <li><strong>Progression to Other Autoimmunity:</strong> Development of Celiac, RA, or Lupus due to "Autoimmune Polyendocrine Syndrome."</li>
            </ol>
        </div>

        <h2 id="viral">The Viral Trigger: EBV and HHV-6</h2>
        <p>Why do antibodies remain high even after a perfect diet? Often, the answer lies in <span class="highlight">Viral Reactivation</span>. The Epstein-Barr Virus (EBV) has a unique affinity for thyroid tissue. A landmark study (n=120) found that <span class="stat-highlight">81%</span> of Hashimoto's patients had evidence of EBV in their thyroid cells, compared to 0% of healthy controls.</p>
        
        <p>Viruses like EBV use a mechanism called "Bystander Activation." When the virus reactivates in the thyroid gland, the immune system rushes in to kill the virus. In the process, it destroys the surrounding thyroid tissue, releasing thyroid proteins (like TPO) into the bloodstream, which then creates more antibodies. This creates a vicious cycle of <span class="highlight">chronic immune activation</span>.</p>

        <h2 id="treg">Modulating the Treg Response: The Peacekeepers</h2>
        <p>If Th1 and Th2 are the "warring factions," <span class="highlight">Regulatory T-cells (Tregs)</span> are the peacekeepers. Their job is to tell the immune system to "stand down" and stop attacking the self. In almost every case of Hashimotoâ€™s, Treg function is compromised.</p>

        <h3>Strategies to Boost Treg Function:</h3>
        <ul class="content-list">
            <li><strong>Vitamin D3/K2:</strong> Vitamin D is a potent Treg inducer. Levels should be optimized to the upper quartile (60â€“80 ng/mL).</li>
            <li><strong>Glutathione:</strong> The master antioxidant helps maintain the redox balance required for Treg survival.</li>
            <li><strong>Short-Chain Fatty Acids (SCFAs):</strong> Produced by gut bacteria from fiber (like butyrate), SCFAs travel to the thymus and bone marrow to stimulate Treg production. This reinforces the <span class="highlight">Gut-Thyroid Axis</span>.</li>
            <li><strong>Low-Dose Naltrexone (LDN):</strong> While a pharmaceutical, coaches should be aware that LDN works primarily by increasing Treg activity and endorphin levels.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">CASE STUDY: The Viral Flare</div>
                <div class="subtitle">Phenotype: Stage 2 Hashimoto's with EBV Reactivation</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">MK</div>
                    <div class="patient-info">
                        <h4>Mark K., 42</h4>
                        <p>Symptoms: Swollen lymph nodes, "crashing" fatigue after exercise, neck pain.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Mark's TSH was 2.1 (perfect), but his TPO antibodies were 900. He felt like he had a permanent flu.</p>
                <p><strong>Intervention:</strong> We focused on the "C" (Clear Toxins/Pathogens) of the B.A.L.A.N.C.E. Method. We introduced high-dose Vitamin D (10,000 IU), Selenium (200mcg), and Monolaurin (an anti-viral coconut derivative).</p>
                <p><strong>Outcome:</strong> Mark's "swollen neck" feeling vanished in 3 weeks. His antibodies dropped to 300 within 6 months, and his exercise tolerance returned.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of Hashimoto's phenotypes.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client presents with Hashimoto's, chronic hives, and severe seasonal allergies. Which immune phenotype is most likely dominant?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Th2 Dominance. Th2 is associated with the humoral immune response, including the production of IgE antibodies, which drive allergic reactions and hives.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the primary reason that "Silent Hashimoto's" (Stage 2) is often missed in conventional medicine?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Because conventional screening typically only looks at TSH. In Stage 2, the thyroid gland is being attacked (antibodies are high), but it is still able to produce enough hormone to keep TSH within the "normal" range.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Hashimotoâ€™s is an immune system disorder, not just a thyroid disorder; the thyroid is merely the victim.</li>
                <li>Th1 dominance involves cellular destruction, while Th2 involves high antibody production and allergic tendencies.</li>
                <li>Molecular mimicry between gluten/dairy and thyroid tissue is a primary driver of the autoimmune "fire."</li>
                <li>Viral reactivation (EBV) can keep antibodies elevated even when the diet is perfect.</li>
                <li>The goal of coaching is to support <strong>Immune Tolerance</strong> by optimizing Treg function and removing triggers.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label" style="font-weight: 600; color: #4c1d95; margin-bottom: 15px;">References & Further Reading</p>
            <ol>
                <li>Akamizu, T. et al. (2021). "Hashimotoâ€™s Thyroiditis: Pathogenesis and Clinical Management." <em>Endocrine Journal</em>.</li>
                <li>Vojdani, A. et al. (2019). "Environmental Triggers and Autoimmunity." <em>Autoimmunity Reviews</em>.</li>
                <li>Janegova, A. et al. (2013). "The Role of Epstein-Barr Virus Infection in the Development of Autoimmune Thyroid Diseases." <em>Endokrynologia Polska</em>.</li>
                <li>Liontiris, M.I. et al. (2017). "A Review of Vitamin D and its Role in Thyroid Disease." <em>Hellenic Journal of Nuclear Medicine</em>.</li>
                <li>Cusick, M.F. et al. (2012). "Molecular Mimicry as a Mechanism of Autoimmune Disease." <em>Clinical Reviews in Allergy & Immunology</em>.</li>
                <li>Pyzik, A. et al. (2015). "Immune Checkpoints in Autoimmune Thyroid Diseases." <em>Journal of Immunology Research</em>.</li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Thyroid Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential & Proprietary.</p>
        </footer>
    </div>
</body>

</html>